Market Overview

CAS Medical Names John Gamelin VP of R&D

Related CASM
CASMED Receives FDA Approval for FORE-SIGHT ELITE in Pediatric and Neonatal Patients
Pharmaceutical Stocks In Play Following Merck/Cubist Deal

CAS Medical Systems, Inc. (Nasdaq: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces the promotion of John Gamelin, Ph.D., to Vice President, Research & Development. Dr. Gamelin has been with CASMED since 2009 and most recently served as Director of Research & Development.

Posted-In: News Management


Related Articles (CASM)

View Comments and Join the Discussion!